Latent tuberculosis infection

From IDWiki
Revision as of 18:26, 19 November 2019 by Aidan (talk | contribs) (Epidemiology: added BCG vaccine)
  • Prior exposure to TB leading to persistent latent tuberculosis, usually contained within lung granulomas
  • Goal is to identify those who are at increased risk of developing active TB and would benefit from treatment to prevent future reactivation
  • Use the TST in 3D calculator and the BCG World Atlas for risk estimation
  • Standard prescription is 4 months of rifampin 10 mg/kg/day (up to 600 mg); counsel patient on side effects and monitor liver enzymes weekly to start

Background

Epidemiology

  • One quarter to one third of the world population has LTBI (estimated at 1.7 billion people)
  • More prevalent in the same countries as active tuberculosis, and is highest in South-East Asia, Pacific, and African regions
  • More common in older patients who would have been exposed when active tuberculosis was more prevalent

BCG vaccination

  • Done routinely in tuberculosis-endemic countries
  • Commonly causes an elevated scar as site of inoculation (often on the deltoid)
    • Compared to smallpox, which forms a crater
  • Receipt of the BCG vaccine affects interpretation of the tuberculin skin test

Investigations

  • Tuberculin skin test (TBST)
    • Sens 90%, Spec >95
  • Interferon-gamma release assay (IGRA)
    • Sn 95%, Sp >95%
    • Preferred for those who have received BCG after infancy

Positive TBST Interpretation

  1. Is it truly positive?
    • Consider IGRA
    • BCG vaccine can be considered a cause of false positive when
      • vaccine given after 12 months of age, and
      • patient has no risk factors, and
      • either Canadian-born non-Aboriginal, or not from endemic country
  2. Rule out active TB
    • signs/symptoms
    • CXR or CT chest
    • Sputum x3 if coughing or cavitary lesions
  3. Evaluate risk of reactivation treatment
    • INH 300 daily x9 mo with pyridoxine
    • baseline liver enzymes and vision testing

Management

  • Standard regimen (9INH) 1
    • Nine months of isoniazid with daily vitamin B6
  • Alternative shorter courses:
    • 4RIF (10 mg/kg [600 mg maximum]): not yet in guidelines, but likely preferred. Slightly higher risk of hepatitis.
    • 6INH
    • 3-4INH/RMP

Further Reading

Tools

References

  1. ^  Canadian Tuberculosis Standards. 7th edition. ed. Template:ISBN. OCLC 978699031.
  2. ^  Dick Menzies, Menonli Adjobimey, Rovina Ruslami, Anete Trajman, Oumou Sow, Heejin Kim, Joseph Obeng Baah, Guy B. Marks, Richard Long, Vernon Hoeppner, Kevin Elwood, Hamdan Al-Jahdali, Martin Gninafon, Lika Apriani, Raspati C. Koesoemadinata, Afranio Kritski, Valeria Rolla, Boubacar Bah, Alioune Camara, Isaac Boakye, Victoria J. Cook, Hazel Goldberg, Chantal Valiquette, Karen Hornby, Marie-Josée Dion, Pei-Zhi Li, Philip C. Hill, Kevin Schwartzman, Andrea Benedetti. Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults. New England Journal of Medicine. 2018;379(5):440-453. doi:10.1056/nejmoa1714283.